Page last updated: 2024-10-21

1-(3-chlorophenyl)piperazine and Dizzyness

1-(3-chlorophenyl)piperazine has been researched along with Dizzyness in 1 studies

1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.

Research Excerpts

ExcerptRelevanceReference
" mCPP's elimination half-life ranged from 2."2.71Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile. ( Bagli, M; Feuchtl, A; Frahnert, C; Kölsch, H; Kühn, KU; Rao, ML; Stephan, R, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feuchtl, A1
Bagli, M1
Stephan, R1
Frahnert, C1
Kölsch, H1
Kühn, KU1
Rao, ML1

Trials

1 trial available for 1-(3-chlorophenyl)piperazine and Dizzyness

ArticleYear
Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile.
    Pharmacopsychiatry, 2004, Volume: 37, Issue:4

    Topics: Administration, Oral; Adrenocorticotropic Hormone; Adult; Anxiety; Auditory Perception; Dizziness; D

2004